Today: 19 July 2026
UiPath stock in focus after CEO discloses fresh share sales ahead of Jan. 2 index add
30 December 2025
1 min read

UiPath stock in focus after CEO discloses fresh share sales ahead of Jan. 2 index add

NEW YORK, December 30, 2025, 03:05 ET — Market closed

  • CEO Daniel Dines disclosed three open-market stock sales totaling 135,000 shares.
  • UiPath shares last traded near $16.85 in late after-hours activity.
  • UiPath is scheduled to join the S&P MidCap 400 before the open on Jan. 2.

UiPath Inc shares were little changed in late after-hours trading on Monday after Chief Executive Daniel Dines disclosed fresh share sales in a regulatory filing. The stock last traded at $16.85, up less than 0.1% from its prior close.

The disclosure lands as investors thin out into year-end and react quickly to insider activity, which can sway sentiment when trading volumes are uneven. It also arrives with UiPath heading into a period of index reshuffling that can create short-term fund flows.

Form 4 filings are required disclosures that show when company insiders buy or sell shares. Dines indicated the trades were made under a Rule 10b5-1 plan, a pre-arranged program that sets trading instructions in advance.

Dines, UiPath’s founder and chairman, sold 45,000 Class A shares on Dec. 24, Dec. 26 and Dec. 29 at reported average prices ranging from about $16.44 to $16.91, the filing showed. The three sales totaled 135,000 shares, roughly $2.3 million based on those average prices.

After the sales, Dines reported direct ownership of 28.57 million Class A shares. The filing also listed 9.62 million shares held indirectly through Ice Vulcan Holding Limited, an entity he controls.

Separately, S&P Dow Jones Indices said UiPath will replace Synovus Financial in the S&P MidCap 400 effective prior to the opening of trading on Jan. 2. Index additions can drive demand from funds that track the benchmark.

UiPath sells software that automates repetitive, rules-based work inside companies, a category known as robotic process automation. The company has been pushing “agentic automation,” which uses AI “agents” to help route tasks across systems under company-set rules.

In its most recent quarterly report, UiPath said revenue rose 16% to $411 million and annual recurring revenue, or ARR — a subscription run-rate metric — climbed 11% to $1.782 billion. “We delivered solid third quarter results, exceeding guidance across the board,” Chief Operating Officer and CFO Ashim Gupta said, as the company forecast fourth-quarter revenue of $462 million to $467 million. UiPath, Inc.

That setup leaves investors focused on whether UiPath can keep expanding ARR and profitability as customers scrutinize big software projects. Traders also watch whether insider selling remains orderly under pre-set plans or starts to look opportunistic if the stock pushes higher.

Before the regular session opens Tuesday, traders will track U.S. housing and rates data including the Case-Shiller home price index and the FHFA house price index, with markets heading into a holiday-shortened stretch. U.S. stock markets are set to stay open on Dec. 31 but close on Jan. 1 for New Year’s Day, with bond trading ending early on Dec. 31, MarketWatch reported.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • CSL Recovers A$16 Billion in Value, Trails Plasma Sector Gains This Week
    July 19, 2026, 3:25 PM EDT. CSL Limited (ASX:CSL) finished July 17 at A$123.32, rising 1.12% on the session and 0.35% for the week, recovering 37% from its 52-week low at A$90 and regaining roughly A$16 billion in valuation. However, CSL underperformed plasma specialists Grifols SA (+1.95%) and Takeda Pharmaceutical (+2.26%) in weekly movement. Trading volume for CSL on Friday came in 14% under its average as 1.62 million shares changed hands. The full-year financial results are due August 18. Still 55% beneath its 52-week peak, CSL's market value stands at A$59.06 billion. The group forecasts FY26 revenues near US$15.2 billion and NPATA of about US$3.1 billion, while a US$5 billion impairment remains subject to audit and board sign-off.
Freeport-McMoRan (FCX) stock slides as metals retreat from record highs; Fed minutes next
Previous Story

Freeport-McMoRan (FCX) stock slides as metals retreat from record highs; Fed minutes next

Bitcoin ATM scam costs Nebraska couple $250,000 as crypto kiosk fraud draws fresh warnings
Next Story

Bitcoin ATM scam costs Nebraska couple $250,000 as crypto kiosk fraud draws fresh warnings

Go toTop